FDA NDC Directory · JSON-LD · Markdown

Linzess

NDC 0456-1202 · HUMAN PRESCRIPTION DRUG · CAPSULE, GELATIN COATED

Generic namelinaclotide
Labeler / ManufacturerAllergan, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA202811
Dosage form / routeCAPSULE, GELATIN COATED · ORAL
Active ingredientsLINACLOTIDE (290 ug/1)
Marketing started20120908
Package count3

External sources

Source: openFDA. Public-domain (CC0).